GHRP-2 Peptide For Sale
Buy GHRP-2 peptide: 5mg listed purchase quantities. Compare live prices across 1 listed vendor with real cost per mg, recorded COA availability and discount codes.
Buy GHRP-2 peptide starting at $17.95/purchase from 1 listed vendor. Compare 5mg purchase quantity options by cost per mg, price per purchase, monthly cost, discount codes and recorded COA metadata (not independent verification).
About GHRP-2
FDA-approved (related product)Also known as: Pralmorelin · KP-102 · GPA-748GHRP-2 (pralmorelin) is a synthetic hexapeptide growth-hormone secretagogue, most often sourced for GH-axis and appetite research. It is approved in Japan as a single-dose diagnostic agent but has no FDA approval in the United States. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.[1]
What to check before you buy GHRP-2:
- A third-party COA with mass-spec confirmation of the hexapeptide sequence — GHRP-2, GHRP-6, and ipamorelin are easily mislabeled for one another and are not interchangeable.
- A COA showing ≥98% purity by HPLC, dated within the last 6–12 months and matching the exact vial size and batch.
- Accurate vial fill matching the label; under-filled vials are a common failure mode that skews reconstitution math.
A single-dose GHRP-2 stimulation test was validated in Japanese pediatric and adult cohorts (Chihara et al.) as a diagnostic alternative to the insulin-tolerance test for severe GH deficiency, supporting its 2006 Japanese regulatory approval.[3] Chronic dosing trials in cachexia (CP-424391-related work) and adult GH deficiency have been published but have not advanced to Phase 3.
Regulatory: Approved in Japan (GHRP Kaken) as a single-dose diagnostic for severe GH deficiency. Not FDA-approved in the United States. Research-grade material elsewhere.
GHRP-2: Mechanisms, Half-Life & Research Data
A skimmable deep dive into how GHRP-2 works and what it is being studied for — tied back to what size to buy. Detailed debates and community notes are tucked into the expandable panels below. All citations resolve to the sources list at the bottom of this page.
How it works
GHRP-2 (pralmorelin) is a synthetic hexapeptide growth-hormone secretagogue (D-Ala-D-βNaphthyl-Ala-Ala-Trp-D-Phe-Lys-NH₂) developed at Tulane University by Cyril Bowers in the 1980s as a tool for studying pulsatile GH release.[1] It is a selective agonist of the ghrelin / growth-hormone-secretagogue receptor (GHS-R1a), expressed on pituitary somatotropes and in hypothalamic appetite-regulating nuclei.[2] Receptor activation triggers GH release through a pathway that is independent of — but synergistic with — GHRH-receptor signalling: combining GHRH with a ghrelin agonist produces a substantially larger GH pulse than either alone, which is the pharmacological rationale for stacking a GHRH analog (Sermorelin, CJC-1295, Tesamorelin) with a ghrelin agonist (GHRP-2, GHRP-6, Ipamorelin) in research-peptide protocols. GHRP-2 also stimulates appetite through the parallel central ghrelin pathway, often within minutes of subcutaneous administration.[6][7] Crucially, GHRP-2 is not perfectly selective for GH release: it produces a measurable rise in prolactin and ACTH/cortisol, distinguishing it from ipamorelin, which Raun and colleagues characterised as the "first selective growth hormone secretagogue" precisely because it lacks this off-target stimulation.[4] Japan approved a single-dose intravenous GHRP-2 test (GHRP Kaken) in 2006 as a diagnostic probe for severe GH deficiency; there is no FDA approval in the United States.
Active research areas
- Diagnostic GH-deficiency testing (approved in Japan)Pihoker and colleagues showed in JCEM 1995 that intravenous and intranasal GHRP-2 produced reproducible GH responses in children with short stature, supporting its development as a stimulation-test reagent.[5] Chihara et al. extended the pharmacokinetic and pharmacodynamic work in adults, providing the basis for Japan's 2006 approval of GHRP Kaken as a single-dose diagnostic alternative to the insulin-tolerance test for severe GH deficiency.[3]
- Adult GH deficiency (chronic dosing, not advanced)Chronic-dosing studies in adults with GH deficiency have been published but have not advanced to Phase 3. The Sigalos/Pastuszak 2018 review summarises that across the GHS class — GHRP-2 included — chronic-dosing safety and efficacy data in adults are limited, and most published human work uses single-dose or short-course protocols.[8]
- Appetite stimulation and cachexiaLaferrère and colleagues published two key human studies showing that subcutaneous GHRP-2 acutely increased food intake by roughly 35% in both lean and obese subjects, accompanied by the expected GH response.[6][7] These data supported the broader hypothesis that ghrelin-receptor agonists could be used to treat cachexia in cancer, COPD, or geriatric anorexia, a programme that progressed further with the non-peptide ghrelin agonist anamorelin than with GHRP-2 itself.
- Selectivity contrast with ipamorelinThe defining pharmacological distinction between GHRP-2 and ipamorelin is selectivity. Raun et al. characterised ipamorelin as the first GHS that releases GH without measurably stimulating ACTH/cortisol or prolactin, directly contrasting it with the cortisol/prolactin signal seen with GHRP-2 and GHRP-6.[4] This is the reason clinicians choosing between the two for chronic dosing typically prefer ipamorelin unless the appetite stimulation of GHRP-2 is itself desired.
Open questions & leading hypotheses (2)
- Hypothesis: Chronic subcutaneous GHRP-2 dosing at "research-peptide" doses (typically 100–300 µg per injection, 1–3 times daily) is metabolically and endocrinologically safe in healthy adults.Evidence: Acute and short-course human studies have not identified serious adverse effects beyond appetite stimulation and the expected GH/cortisol/prolactin rises,[3][5][6] and Japan's diagnostic use is well-established.[3] Counter-evidence: no Phase 3 chronic-dosing programme exists; the cortisol and prolactin signals that distinguish GHRP-2 from ipamorelin imply that long-term daily use could plausibly produce cumulative HPA-axis or prolactin-related effects that single-dose studies cannot capture.[4][8] The Sigalos/Pastuszak review is explicit that controlled chronic-dosing safety data for the GHS class as a whole are lacking.[8]
- Hypothesis: GHRP-2 and ipamorelin are equivalent for users who only care about the GH/IGF-1 response and not about cortisol/prolactin.Evidence: Both molecules are GHS-R1a agonists and both produce reproducible GH pulses in humans; on a milligram-for-milligram basis their GH-releasing potency is comparable.[1][2][4] Counter-evidence: in head-to-head pharmacology studies, the cortisol/prolactin signal with GHRP-2 is not zero; in users dosing daily or multiple times per day this off-target stimulation may matter for sleep, mood, body composition, and (in women) menstrual regularity, even if the GH response is identical.[4] The honest answer is that this depends on the user's goals: GHRP-2 wins if appetite stimulation is desired; ipamorelin wins on selectivity.
What community users report
Anecdotal — not controlled-trial evidence
On r/Peptides and r/PeptideAdmin, GHRP-2 users most often run 100–300 µg per injection, one to three times per day, either solo or stacked with a GHRH analog (Sermorelin, Mod-GRF-1-29, or CJC-1295 no-DAC) to amplify the GH pulse.[9][10] The most consistent subjective reports are a strong, fast-onset hunger surge within 10–20 minutes of subcutaneous injection — distinguishing GHRP-2 from the comparatively "neutral" ipamorelin and making it useful for users trying to gain weight or treat anorexia and unpleasant for users running a calorie deficit. Other common reports include improved sleep depth on a pre-bed dose, a transient flush or tingling at injection, and a small cohort describing low-grade lethargy or "blunted mood" on chronic dosing that they attribute to the documented cortisol/prolactin component. Many threads compare GHRP-2 head-to-head with ipamorelin and converge on the same trade-off: GHRP-2 for stronger appetite and slightly stronger GH pulses, ipamorelin for cleaner side-effect profile on chronic use. **These reports are anecdotal and have not been validated in controlled trials.** They are useful for understanding what self-experimenters notice but do not establish that chronic subcutaneous GHRP-2 dosing is safe or effective for any indication — the only properly controlled human evidence is the single-dose diagnostic data that supports the Japanese approval.
Sources & references (10)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Bowers CY et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537–1545. · PMID: 6714155 link
- [2]Smith RG et al. A nonpeptidyl growth hormone secretagogue. Science 1993;260:1640–1643. · PMID: 8503009 link
- [3]Chihara K et al. Repeated administration of GHRP-2 in normal subjects: pharmacokinetic and pharmacodynamic effects on serum GH. Endocr J 2007;54:415–420. · PMID: 17446666 link
- [4]Raun K, Hansen BS, Johansen NL et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998;139:552–561. · PMID: 9849822 link
- [5]Pihoker C, Kearns GL, French D, Bowers CY. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. JCEM 1995;80:2987–2992. · PMID: 7559885 link
- [6]Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. JCEM 2005;90:611–614. · PMID: 15699539 link
- [7]Laferrère B, Hart AB, Bowers CY. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake and growth hormone secretion. Obesity (Silver Spring) 2006;14:1056–1063. · PMID: 16861611 link
- [8]Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev 2018;6:45–53. · PMID: 28400207 link
- [9]Community report — r/Peptides GHRP-2 vs. Ipamorelin selectivity and side-effect discussions (subreddit), accessed May 2026. link
- [10]Community report — r/PeptideAdmin GHRP-2 dosing and stacking threads (subreddit), accessed May 2026. link
What GHRP-2 Costs Right Now
WPA currently tracks GHRP-2 from 1 distinct vendor. The cheapest in-stock GHRP-2 listing is $17.95. Swiss Chems holds the lowest sticker price at $17.95. Normalized to milligrams, GHRP-2 costs $3.59/mg on this page. The best per-milligram value is the listed 5 mg purchase quantity from Swiss Chems.
GHRP-2 is stocked in a single size: 5 mg listed quantity; vial count not recorded. Because vials of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.
GHRP-2 Calculator Input Observations
In lifetime GHRP-2 calculator inputs, 150mcg is the most frequent entered amount (27 of 91 runs). Separately, 2x/week is the most frequent overall cadence (4 of 19 lifetime frequency responses, across entered amounts). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. As nominal quantity arithmetic only, 5 mg of listed product divided by 0.15 mg gives roughly 33 portions before preparation losses. This does not establish vial count, stability after preparation, or cycle length.
GHRP-2 Discount Codes
1 of the 1 tracked GHRP-2 listing carries a WPA researcher discount code. The largest live discount is 10% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.
About GHRP-2
GHRP-2 (pralmorelin) is a synthetic hexapeptide growth-hormone secretagogue, most often sourced for GH-axis and appetite research. It is approved in Japan as a single-dose diagnostic agent but has no FDA approval in the United States. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.
GHRP-2 is tracked under the Muscle Peptides category on WPA. Its reported half-life is ~30 min. Calculator inputs do not establish why a cadence was selected or validate a protocol. Approved in Japan (GHRP Kaken) as a single-dose diagnostic for severe GH deficiency.
How to Read the GHRP-2 Comparison
- Price per milligram — Every GHRP-2 listing is normalized to $3.59/mg-style unit pricing, so a small cheap vial cannot hide a worse real cost than a larger one.
- Stock status — Live in-stock state for each GHRP-2 listing, refreshed on a recurring basis.
Frequently Asked Questions: GHRP-2
Is it legal and safe to buy GHRP-2 for research?
In the US, GHRP-2 is sold strictly as a research chemical — legal to buy for laboratory research but not approved for human use. It is a synthetic growth-hormone-releasing peptide with no approved human form, sold strictly for laboratory research. The real variable isn't legality, it's quality: unverified suppliers can ship underdosed, impure, or mislabeled material. WPA records COA-related listing fields where supplied, but does not independently verify every report. Inspect the actual batch report and its laboratory, identity testing, and date before drawing conclusions. Right now that screen covers 1 GHRP-2 listing from 1 vendor.
How do I verify a GHRP-2 COA so I'm not getting an underdosed vial?
A Certificate of Analysis (COA) may report tests for a specific GHRP-2 batch. Check that the report identifies the compound (actually GHRP-2, not GHRP-6 or an underdosed vial), names the laboratory, describes the test method and result, and matches the offered batch and date. A recorded purity value or COA-availability flag in WPA's listing data is not independent verification. Open the vendor listing and inspect the actual report before drawing conclusions. No GHRP-2 listing tracked on this page is marked as having COA availability in WPA's listing data; this does not establish whether vendors have reports.
Which GHRP-2 vendor should I pick?
There's no single "best" GHRP-2 vendor — it depends on what you weigh most. WPA ranks tracked listings using recorded purity and date fields where available, visitor click activity, price, stock status, and discount data; this ranking is not independent verification of a report. Only Swiss Chems stocks GHRP-2 among tracked vendors right now, so there is no price competition to arbitrage — weight the COA rather than the price. Review the actual report and confirm its batch details before making a decision.
How much does GHRP-2 cost — and how do I know I'm not overpaying?
Judge GHRP-2 by true price per milligram, not the sticker price on one vial — a cheap small vial often costs more per mg than a larger one. It most often ships in 5 mg vials, so compare $/mg across those rather than the sticker price on one vial. The best tracked GHRP-2 listing works out to $3.59/mg on the listed 5 mg purchase quantity. WPA normalizes tracked listings to $/mg, and the live cost-per-month card estimates your spend at the most common dose. The one catch: the lowest $/mg sometimes means buying a bigger vial than your cycle needs.
How much GHRP-2 do I need for one full cycle?
In lifetime GHRP-2 calculator inputs, 150mcg is the most frequent entered amount (27 of 91 runs). Separately, 2x/week is the most frequent overall cadence (4 of 19 lifetime frequency responses, across entered amounts). Calculator runs and frequency responses are different populations, not unique people or confirmed administration. Separate modal inputs do not establish a most-common joint protocol, a recommendation, or a cycle length. Dividing the listed 5 mg purchase quantity by 0.15 mg gives roughly 33 nominal portions before preparation losses; vial count and stability after preparation are separate questions. A cycle requires an independently chosen amount, cadence and time horizon; calculator observations do not supply those decisions. Compare nominal package quantities and model your own selections in the cost card.
Are discount codes available for GHRP-2?
Participating GHRP-2 vendors may offer WPA researcher discount codes. Codes can change, exclude sale items or carry order minimums. 1 of the 1 tracked GHRP-2 listings carry a code right now, the largest worth 10% off. Each listing shows the recorded code and discounted price where available; confirm the actual package and checkout terms with the vendor.
Where can I compare GHRP-2 prices and listing details?
This comparison shows 1 tracked listings for GHRP-2 in the selected format. Compare purchase price, established nominal quantities, discount terms and recorded COA availability, purity and date fields. Those fields are not independent verification. Inspect actual batch reports and confirm package composition and checkout price on the vendor's site.